Stock Analysis on Net
Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

Common Stock Valuation Ratios (Price Multiples)
Quarterly Data

Beginner level

Historical Valuation Ratios (Summary)

Medtronic PLC, historical price multiples (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014
Price to earnings (P/E) 26.30 25.38 31.86 32.75 28.78 25.11 57.38 41.16 37.80 37.82 21.55 26.35 29.96 28.24 23.20 32.64 33.17 43.49 47.09 37.49 40.56
Price to operating profit (P/OP) 26.29 21.01 23.52 22.21 21.26 19.74 21.13 20.04 17.64 16.73 17.82 19.53 22.64 21.53 18.18 22.35 22.18 25.45 26.74 25.83 28.81
Price to sales (P/S) 4.36 4.34 4.82 4.72 4.36 4.04 4.27 4.35 3.92 3.57 3.65 3.62 4.06 3.82 3.39 4.14 4.07 3.70 4.20 4.23 5.36
Price to book value (P/BV) 2.48 2.60 2.94 2.87 2.66 2.48 2.62 2.59 2.31 2.11 2.10 2.14 2.40 2.27 1.96 2.34 2.25 2.08 2.09 1.86 2.04 3.79 3.72 3.25

Based on: 10-K (filing date: 2020-06-19), 10-Q (filing date: 2020-02-28), 10-Q (filing date: 2019-12-03), 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29).

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. Medtronic PLC’s P/E ratio decreased from Q2 2020 to Q3 2020 but then slightly increased from Q3 2020 to Q4 2020.
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. Medtronic PLC’s P/OP ratio decreased from Q2 2020 to Q3 2020 but then increased from Q3 2020 to Q4 2020 exceeding Q2 2020 level.
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. Medtronic PLC’s P/S ratio decreased from Q2 2020 to Q3 2020 but then slightly increased from Q3 2020 to Q4 2020.
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company’s required rate of return and its actual rate of return. Medtronic PLC’s P/BV ratio decreased from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.

Price to Earnings (P/E)

Medtronic PLC, historical P/E calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014
No. shares of common stock outstanding1 1,341,298,882 1,340,166,137 1,340,377,511 1,341,669,471 1,341,156,703 1,341,150,970 1,343,045,417 1,350,511,193 1,351,709,097 1,355,373,428 1,353,498,000 1,354,591,435 1,359,026,669 1,368,884,991 1,373,047,310 1,381,935,603 1,394,731,892 1,401,043,252 1,406,155,722 1,413,614,665 1,416,351,117 984,316,549 984,316,549 979,516,413
Selected Financial Data (US$)
Net income (loss) attributable to Medtronic (in millions) 646  1,915  1,364  864  1,172  1,269  1,115  1,075  1,460  (1,389) 2,017  1,016  1,163  821  1,115  929  1,103  1,095  520  820  (1) 977  828  871 
Earnings per share (EPS)2 3.57 3.97 3.48 3.29 3.45 3.67 1.68 2.34 2.30 2.07 3.71 3.04 2.96 2.90 3.09 2.64 2.54 1.74 1.65 1.86 1.89 0.00 0.00 0.00
Share price1, 3 93.91 100.67 110.99 107.89 99.38 92.09 96.60 96.41 86.81 78.33 79.87 80.05 88.79 81.86 71.67 86.15 84.14 75.55 77.56 69.59 76.61 77.59 73.48 63.85
Valuation Ratio
P/E ratio4 26.30 25.38 31.86 32.75 28.78 25.11 57.38 41.16 37.80 37.82 21.55 26.35 29.96 28.24 23.20 32.64 33.17 43.49 47.09 37.49 40.56
Benchmarks
P/E Ratio, Competitors5
Becton, Dickinson & Co. 95.62 75.45 90.00 65.09 83.38 66.87 72.88 408.36 105.60 206.04 49.63 59.56 30.05 28.94 36.65 32.09 43.18 41.64 45.52 38.75 27.56 24.05
Boston Scientific Corp. 13.68 13.56 11.72 11.86 51.90 42.77 28.42 33.06 73.07 89.21 363.19 354.70 44.70 46.56 83.30 96.19 362.11
Danaher Corp. 46.61 41.91 35.88 38.34 40.31 41.93 37.63 29.77 25.70 27.06 27.78 27.25 26.31 26.25 25.00 23.02 22.23 16.01 18.64 17.85
Edwards Lifesciences Corp. 61.28 65.79 39.74 46.05 61.52 61.07 47.99 51.14 41.12 45.24 48.67 48.16 28.95 34.05 35.04 33.48 37.26 46.13 43.71 37.39
Intuitive Surgical Inc. 82.17 70.73 44.28 48.72 49.80 51.02 53.16 53.03 73.32 73.33 69.50 70.95 45.87 42.21 38.18 37.16 36.58 39.90 37.79 34.24
Stryker Corp. 43.23 45.35 31.33 39.24 23.72 22.60 19.64 18.96 48.55 58.86 62.59 54.36 33.60 32.52 29.96 27.92 25.79 27.29 25.30 24.92
Thermo Fisher Scientific Inc. 38.43 44.19 35.50 33.36 33.89 31.08 35.11 35.19 36.71 39.27 37.52 37.66 33.39 30.36 30.83 30.45 29.02 31.09 29.03 26.19
UnitedHealth Group Inc. 17.70 16.88 19.91 20.48 17.79 17.98 17.93 21.09 21.18 20.91 20.02 20.77 23.90 23.24 22.18 21.73 20.76 22.06 20.88 18.18

Based on: 10-K (filing date: 2020-06-19), 10-Q (filing date: 2020-02-28), 10-Q (filing date: 2019-12-03), 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29).

1 Data adjusted for splits and stock dividends.

2 Q4 2020 Calculation
EPS = (Net income (loss) attributable to MedtronicQ4 2020 + Net income (loss) attributable to MedtronicQ3 2020 + Net income (loss) attributable to MedtronicQ2 2020 + Net income (loss) attributable to MedtronicQ1 2020) ÷ No. shares of common stock outstanding
= (646,000,000 + 1,915,000,000 + 1,364,000,000 + 864,000,000) ÷ 1,341,298,882 = 3.57

3 Closing price as at the filing date of Medtronic PLC’s Quarterly or Annual Report.

4 Q4 2020 Calculation
P/E ratio = Share price ÷ EPS
= 93.91 ÷ 3.57 = 26.30

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. Medtronic PLC’s P/E ratio decreased from Q2 2020 to Q3 2020 but then slightly increased from Q3 2020 to Q4 2020.

Price to Operating Profit (P/OP)

Medtronic PLC, historical P/OP calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014
No. shares of common stock outstanding1 1,341,298,882 1,340,166,137 1,340,377,511 1,341,669,471 1,341,156,703 1,341,150,970 1,343,045,417 1,350,511,193 1,351,709,097 1,355,373,428 1,353,498,000 1,354,591,435 1,359,026,669 1,368,884,991 1,373,047,310 1,381,935,603 1,394,731,892 1,401,043,252 1,406,155,722 1,413,614,665 1,416,351,117 984,316,549 984,316,549 979,516,413
Selected Financial Data (US$)
Operating profit (in millions) 316  1,639  1,351  1,485  1,946  1,542  1,544  1,236  1,935  1,426  1,901  1,389  1,631  1,147  1,385  1,167  1,505  1,355  1,300  1,131  373  1,275  1,030  1,088 
Operating profit per share2 3.57 4.79 4.72 4.86 4.67 4.67 4.57 4.81 4.92 4.68 4.48 4.10 3.92 3.80 3.94 3.85 3.79 2.97 2.90 2.69 2.66 0.00 0.00 0.00
Share price1, 3 93.91 100.67 110.99 107.89 99.38 92.09 96.60 96.41 86.81 78.33 79.87 80.05 88.79 81.86 71.67 86.15 84.14 75.55 77.56 69.59 76.61 77.59 73.48 63.85
Valuation Ratio
P/OP ratio4 26.29 21.01 23.52 22.21 21.26 19.74 21.13 20.04 17.64 16.73 17.82 19.53 22.64 21.53 18.18 22.35 22.18 25.45 26.74 25.83 28.81
Benchmarks
P/OP Ratio, Competitors5
Becton, Dickinson & Co. 56.20 43.34 49.82 40.02 29.43 29.40 30.27 43.37 47.87 95.72 67.53 34.59 40.06 21.15 20.05 25.02 22.42 27.98 26.60 29.46 26.74 19.97 17.53
Boston Scientific Corp. 630.22 80.81 44.72 36.71 34.77 36.58 31.15 36.68 32.51 31.09 30.63 28.71 34.07 34.07 69.95 74.67 814.74
Danaher Corp. 46.28 43.09 35.22 34.47 29.97 30.85 26.85 23.18 20.95 21.72 22.58 22.48 22.35 21.13 20.83 21.37 18.48 18.09 19.87 17.27
Edwards Lifesciences Corp. 56.78 61.66 35.77 42.04 57.30 56.37 47.70 49.37 26.74 28.00 25.96 25.66 22.59 26.24 26.76 25.38 28.50 35.53 34.06 29.11
Intuitive Surgical Inc. 83.88 71.30 43.68 48.89 50.00 49.12 51.89 49.87 48.90 50.69 46.82 44.40 41.74 35.53 31.07 28.93 28.50 31.46 30.10 27.24
Stryker Corp. 31.40 33.20 24.04 30.13 32.94 33.22 27.96 26.55 23.52 25.45 27.41 24.21 26.70 25.11 22.99 21.23 19.87 21.42 20.73 19.27
Thermo Fisher Scientific Inc. 31.49 36.59 28.44 26.84 26.99 24.59 28.45 27.33 26.24 28.33 26.99 28.24 28.12 25.79 26.21 25.13 24.26 25.78 24.44 22.15
UnitedHealth Group Inc. 12.35 11.85 13.80 14.40 12.43 12.51 12.48 14.58 15.82 15.19 14.17 14.42 14.30 13.54 12.56 11.79 11.14 11.71 11.07 9.59

Based on: 10-K (filing date: 2020-06-19), 10-Q (filing date: 2020-02-28), 10-Q (filing date: 2019-12-03), 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29).

1 Data adjusted for splits and stock dividends.

2 Q4 2020 Calculation
Operating profit per share = (Operating profitQ4 2020 + Operating profitQ3 2020 + Operating profitQ2 2020 + Operating profitQ1 2020) ÷ No. shares of common stock outstanding
= (316,000,000 + 1,639,000,000 + 1,351,000,000 + 1,485,000,000) ÷ 1,341,298,882 = 3.57

3 Closing price as at the filing date of Medtronic PLC’s Quarterly or Annual Report.

4 Q4 2020 Calculation
P/OP ratio = Share price ÷ Operating profit per share
= 93.91 ÷ 3.57 = 26.29

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. Medtronic PLC’s P/OP ratio decreased from Q2 2020 to Q3 2020 but then increased from Q3 2020 to Q4 2020 exceeding Q2 2020 level.

Price to Sales (P/S)

Medtronic PLC, historical P/S calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014
No. shares of common stock outstanding1 1,341,298,882 1,340,166,137 1,340,377,511 1,341,669,471 1,341,156,703 1,341,150,970 1,343,045,417 1,350,511,193 1,351,709,097 1,355,373,428 1,353,498,000 1,354,591,435 1,359,026,669 1,368,884,991 1,373,047,310 1,381,935,603 1,394,731,892 1,401,043,252 1,406,155,722 1,413,614,665 1,416,351,117 984,316,549 984,316,549 979,516,413
Selected Financial Data (US$)
Net sales (in millions) 5,997  7,717  7,706  7,493  8,146  7,546  7,481  7,384  8,144  7,369  7,050  7,390  7,916  7,283  7,345  7,166  7,567  6,934  7,058  7,274  7,304  4,318  4,366  4,273 
Sales per share2 21.56 23.18 23.05 22.86 22.78 22.78 22.62 22.17 22.16 21.93 21.90 22.10 21.86 21.45 21.13 20.79 20.67 20.39 18.46 16.46 14.31 0.00 0.00 0.00
Share price1, 3 93.91 100.67 110.99 107.89 99.38 92.09 96.60 96.41 86.81 78.33 79.87 80.05 88.79 81.86 71.67 86.15 84.14 75.55 77.56 69.59 76.61 77.59 73.48 63.85
Valuation Ratio
P/S ratio4 4.36 4.34 4.82 4.72 4.36 4.04 4.27 4.35 3.92 3.57 3.65 3.62 4.06 3.82 3.39 4.14 4.07 3.70 4.20 4.23 5.36
Benchmarks
P/S Ratio, Competitors5
Becton, Dickinson & Co. 4.45 4.00 3.94 4.07 3.82 3.64 3.82 4.06 4.45 4.49 4.94 4.23 3.72 3.21 3.05 2.87 2.97 2.86 2.55 3.08 3.35 3.51 3.26
Boston Scientific Corp. 4.99 5.31 4.66 5.19 5.44 5.92 5.14 5.62 5.06 4.89 4.39 4.08 4.27 4.21 4.22 3.98 3.59 4.08 3.86 3.13
Danaher Corp. 8.15 7.48 6.34 6.29 5.32 5.43 4.67 3.97 3.62 3.74 3.77 3.70 3.52 3.32 3.35 3.48 3.05 2.94 3.34 2.91
Edwards Lifesciences Corp. 11.14 11.32 9.82 11.09 11.46 11.17 9.61 9.92 8.06 8.37 7.91 8.18 6.51 7.55 7.31 6.43 7.17 8.89 8.65 7.42
Intuitive Surgical Inc. 20.09 18.44 13.33 15.01 15.41 15.28 15.83 16.06 16.36 17.01 16.16 14.96 13.83 12.01 10.69 10.11 10.06 10.69 9.70 8.46
Stryker Corp. 5.34 5.16 4.53 5.49 5.59 5.65 4.98 4.95 4.52 4.88 5.01 4.46 4.93 4.62 4.29 4.06 3.93 4.18 4.07 3.61
Thermo Fisher Scientific Inc. 6.58 6.24 5.08 4.83 4.83 4.43 4.52 4.24 3.95 4.07 3.84 4.01 3.92 3.58 3.57 3.37 3.22 3.53 3.34 3.05
UnitedHealth Group Inc. 1.18 1.17 1.12 1.18 1.00 1.00 0.98 1.12 1.22 1.17 1.09 1.10 1.05 0.98 0.89 0.83 0.75 0.78 0.76 0.68

Based on: 10-K (filing date: 2020-06-19), 10-Q (filing date: 2020-02-28), 10-Q (filing date: 2019-12-03), 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29).

1 Data adjusted for splits and stock dividends.

2 Q4 2020 Calculation
Sales per share = (Net salesQ4 2020 + Net salesQ3 2020 + Net salesQ2 2020 + Net salesQ1 2020) ÷ No. shares of common stock outstanding
= (5,997,000,000 + 7,717,000,000 + 7,706,000,000 + 7,493,000,000) ÷ 1,341,298,882 = 21.56

3 Closing price as at the filing date of Medtronic PLC’s Quarterly or Annual Report.

4 Q4 2020 Calculation
P/S ratio = Share price ÷ Sales per share
= 93.91 ÷ 21.56 = 4.36

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. Medtronic PLC’s P/S ratio decreased from Q2 2020 to Q3 2020 but then slightly increased from Q3 2020 to Q4 2020.

Price to Book Value (P/BV)

Medtronic PLC, historical P/BV calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014
No. shares of common stock outstanding1 1,341,298,882 1,340,166,137 1,340,377,511 1,341,669,471 1,341,156,703 1,341,150,970 1,343,045,417 1,350,511,193 1,351,709,097 1,355,373,428 1,353,498,000 1,354,591,435 1,359,026,669 1,368,884,991 1,373,047,310 1,381,935,603 1,394,731,892 1,401,043,252 1,406,155,722 1,413,614,665 1,416,351,117 984,316,549 984,316,549 979,516,413
Selected Financial Data (US$)
Shareholders’ equity (in millions) 50,737  51,808  50,578  50,363  50,091  49,829  49,607  50,224  50,720  50,234  51,469  50,672  50,294  49,387  50,186  50,824  52,063  50,816  52,269  52,809  53,230  20,173  19,438  19,248 
Book value per share (BVPS)2 37.83 38.66 37.73 37.54 37.35 37.15 36.94 37.19 37.52 37.06 38.03 37.41 37.01 36.08 36.55 36.78 37.33 36.27 37.17 37.36 37.58 20.49 19.75 19.65
Share price1, 3 93.91 100.67 110.99 107.89 99.38 92.09 96.60 96.41 86.81 78.33 79.87 80.05 88.79 81.86 71.67 86.15 84.14 75.55 77.56 69.59 76.61 77.59 73.48 63.85
Valuation Ratio
P/BV ratio4 2.48 2.60 2.94 2.87 2.66 2.48 2.62 2.59 2.31 2.11 2.10 2.14 2.40 2.27 1.96 2.34 2.25 2.08 2.09 1.86 2.04 3.79 3.72 3.25
Benchmarks
P/BV Ratio, Competitors5
Becton, Dickinson & Co. 3.13 3.32 3.23 3.34 3.04 2.91 3.05 3.09 3.07 2.87 2.85 3.95 3.60 4.96 4.99 4.69 4.55 4.56 3.97 4.42 4.35 4.15 5.46
Boston Scientific Corp. 3.24 3.46 3.64 4.02 5.83 6.33 5.53 6.33 5.91 6.00 5.79 5.26 4.97 5.07 5.14 4.96 4.52 5.22 4.58 3.70 3.92 3.56 3.57
Danaher Corp. 4.38 3.90 3.68 3.72 3.02 3.19 2.88 2.80 2.56 2.65 2.61 2.58 2.47 2.35 2.42 2.56 2.39 2.24 2.70 2.53 2.79 2.53 2.57
Edwards Lifesciences Corp. 11.56 12.74 11.29 11.62 12.48 12.65 10.65 11.76 8.72 9.39 8.40 9.51 6.82 8.30 8.39 7.28 7.64 9.86 9.78 7.39 6.90 7.22 6.31
Intuitive Surgical Inc. 9.35 9.19 7.22 8.13 8.43 8.49 8.68 8.96 9.30 10.03 9.71 9.91 8.35 7.62 7.21 4.73 4.77 5.22 5.00 4.67 4.53 5.37 5.31
Stryker Corp. 5.85 5.69 5.17 6.38 6.60 6.72 5.92 5.74 6.09 6.72 6.92 5.56 5.73 5.51 5.21 4.82 4.59 4.81 4.65 4.21 4.18 4.52 4.19
Thermo Fisher Scientific Inc. 5.89 5.48 4.56 4.16 4.15 3.83 4.02 3.75 3.51 3.55 3.24 3.30 3.14 3.07 3.07 2.86 2.67 2.92 2.76 2.42 2.50 2.69 2.55
UnitedHealth Group Inc. 4.54 4.53 4.81 4.92 4.32 4.40 4.37 4.89 5.32 5.13 4.72 4.59 4.55 4.37 4.01 3.98 3.61 3.75 3.57 3.12 3.35 3.51 3.39

Based on: 10-K (filing date: 2020-06-19), 10-Q (filing date: 2020-02-28), 10-Q (filing date: 2019-12-03), 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29).

1 Data adjusted for splits and stock dividends.

2 Q4 2020 Calculation
BVPS = Shareholders’ equity ÷ No. shares of common stock outstanding
= 50,737,000,000 ÷ 1,341,298,882 = 37.83

3 Closing price as at the filing date of Medtronic PLC’s Quarterly or Annual Report.

4 Q4 2020 Calculation
P/BV ratio = Share price ÷ BVPS
= 93.91 ÷ 37.83 = 2.48

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company’s required rate of return and its actual rate of return. Medtronic PLC’s P/BV ratio decreased from Q2 2020 to Q3 2020 and from Q3 2020 to Q4 2020.